Concepedia

Kori Wallace

KW

31

Publications

3.2K

Citations

20

H-Index

1998

Active since

Affiliations

AbbVie (United States)(Current)

KU Leuven

AbbVie (Germany)

University of Calgary

Western University

Kori Wallace is an author at AbbVie (United States) specializing in medicine, gastroenterology, and immunology.

Top concepts

Publications per year

1998–2024

31

Publications

31

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

, , +3

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Geert D’Haens, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 362 citations

, , +9

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

Marc Ferrante, Remo Panaccione, Filip Baert et al. · The Lancet · 2022 · 294 citations

, , +7

P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease

Renata Polanowska‐Grabowska, Kori Wallace, Joshua J. Field et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 175 citations · Full text

Selenium and Colorectal Adenoma: Results of a Pooled Analysis

Elizabeth T. Jacobs, Ruixuan Jiang, David S. Alberts et al. · JNCI Journal of the National Cancer Institute · 2004 · 157 citations · Full text

Rows per page

1–5 of 31